Skip to content
Precision for Medicine
AdobeStock_183200379

Clinical Trial Management Services

Execute your trials with Precision: Unrivaled Clinical Trial Management for global impact
Empower your clinical research with Precision for Medicine's bespoke Clinical Trial Management Services. Our approach seamlessly blends innovation in early-phase trials with robust effectiveness in late phases, ensuring your research advances confidently towards its goals. With an unwavering commitment to excellence, we propel the advancement of life-changing therapies for patients in need around the globe.

End-to-end Clinical Trial Management services

Precision for Medicine's end-to-end capabilities unite expert teams and global reach with advanced processes and technologies. By transforming complex data into actionable insights, we not only navigate the intricacies of each phase but also empower each trial with the agility and insight needed to drive success from concept to conclusion. Our strategic and collaborative approach to clinical trial management services accelerates trial success, setting new industry standards.

CRO Leadership Awards 2024

Award-winning clinical trial management services

Precision for Medicine's receipt of the 2024 CRO Leadership Awards in every category signifies more than our excellence; it highlights our partnership's value in propelling your clinical trials forward. Our award-winning expertise delivers not just superior trial management but a shared mission in bringing transformative therapies to patients globally.

See how our consistent recognition in the industry underscores our commitment to excellence in clinical trial management.

3500 Experts fueling innovation
600 Global trials driving progress
20 Years of clinical excellence

Advancing outcomes at every stage

  • Discover Early Phase Excellence
    clinical trial patient doctor

    Early Phase Excellence

    Embark on the critical first steps of clinical discovery with our expertly managed early phase trials, where meticulous attention meets innovative strategy.

    Explore
  • Discover Late Phase Success
    patient on bed clinical

    Late Phase Success

    Discover the path to market with our Late Phase Development expertise – delivering precision, compliance, and efficiency for your clinical journey.

    Explore

Deep experience with debilitating disease and unique modalities

Like you, we understand that there’s a patient throughout the development pathway. Supporting our partners to bring innovative treatments to patients is our purpose. Leverage our experience in these therapeutic areas.

Specialized capabilities in every stage of clinical development

Leverage an integrated infrastructure that reduces the inefficiencies inherent in complex development. Integrate lab and trial execution to accelerate speed to market. Precision can customize and converge our capabilities to meet your program's unique needs—driving efficiency, agility, and success from start to finish.

  • Discover Explore
    clinical-trial-support

    Global CRO Services

    A recognized leader in oncology and rare diseases with rich experience in complex trials

    Explore
  • Discover Explore
    specialty-lab-services

    Laboratory
    Services

    Experts in translational and biomarker sciences with worldwide specialty labs and clinical logistics services that are enabling breakthroughs.

    Explore

Read our latest Precision insights

Stay updated with the latest insights in statistical programming and automation through our blog. 

Read: Receptor Occupancy in the Era of Multispecific Therapeutics Receptor Occupancy in the Era of Multispecific Therapeutics

Translational Research - Lab Services

Receptor Occupancy in the Era of Multispecific Therapeutics

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=159488778875, hs_child_table_id=0, hs_updated_at=1716454216458, hs_published_at=1785259834087, description=Pharma industry veteran and expert at biomarker-driven clinical trial design and execution. Leader of biomarker and drug development programs for pharmaceutical and diagnostics companies, as well as the National Institutes of Health. Spearheaded the discovery of pharmacodynamic biomarkers and novel targets for inflammatory disease therapy., avatar=Image{width=576,height=576,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/Headshots/Headshots%20no%20background/Deb%20Phippard.webp',altText='Deb Phippard',fileId=165892372605}, linkedin=https://www.linkedin.com/in/deb-phippard-103b54, team=[{id=163072475007, name='Precision for Medicine Leadership'}], hs_name=, hs_path=, lastname=Phippard, PhD, hs_initial_published_at=1775839468505, hs_created_at=1709645745106, hs_is_edited=false, hs_deleted_at=0, name=Deborah, job= Chief Scientific Officer, slug=deborah-phippard, email=, hs_updated_by_user_id=51739740}, second={hs_id=218178874459, hs_child_table_id=0, hs_updated_at=1785241362455, hs_published_at=1785259834087, description=Jenny Zilberberg has more than 20 years of combined experience across academia and biotechnology, with expertise in translational immunology, cancer immunotherapy, and biomarker strategy. Most recently, she served as Head of Research at Imvax, where she led preclinical development and biomarker activities for the company’s immunotherapy platform and lead glioblastoma program. At Precision, Jenny partners with sponsors to design and implement biomarker and bioanalytical solutions that support clinical development across oncology and autoimmune diseases., avatar=Image{width=480,height=480,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/JennyZilberberg.jpeg',altText='JennyZilberberg',fileId=218182303073}, lastname=Zilberberg, hs_initial_published_at=1785241367324, hs_created_by_user_id=65712240, hs_created_at=1785241302354, hs_is_edited=false, hs_deleted_at=0, name=Jenny, job=Vice President, Scientific Strategy, slug=Jenny-zilberberg, hs_updated_by_user_id=51739740}, third={}})
  • Deborah P. avatar

    Deborah P.

  • Jenny Z. avatar

    Jenny Z.

Discover
Read: Case Study: Prescreening Intel Restores Phase 3 Colorectal Enrollment Case Study: Prescreening Intel Restores Phase 3 Colorectal Enrollment

Case Study: Prescreening Intel Restores Phase 3 Colorectal Enrollment

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=217320686850, hs_child_table_id=0, hs_updated_at=1784229354065, hs_published_at=1785259834087, description=Erica Donnelly is a Senior Clinical Trial Manager with over 18 years of experience in the pharmaceutical and CRO industries. She has experience in Phase I-III clinical trials. She has experience in global vendor management and leading teams of CRAs and CTAs. Erica has oncology therapeutic experience including AML., avatar=Image{width=800,height=800,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/1604417210025.jpeg',altText='1604417210025',fileId=217303275102}, lastname=Donnelly, hs_initial_published_at=1784230182153, hs_created_by_user_id=65712240, hs_created_at=1784229139957, hs_is_edited=false, hs_deleted_at=0, name=Erica, job=Senior Clinical Trial Manager, slug=erica-donnelly, hs_updated_by_user_id=51739740}, second={}, third={}})
  • Erica Donnelly avatar

    Erica Donnelly

Discover
Read: Case Study: Theranostic Radiopharm Trial and Evolving FDA Expectations Case Study: Theranostic Radiopharm Trial and Evolving FDA Expectations

Case Study: Theranostic Radiopharm Trial and Evolving FDA Expectations

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=217320686763, hs_child_table_id=0, hs_updated_at=1784229018395, hs_published_at=1785259834087, description=Rachel Piacente is a Clinical Trial Manager at Precision for Medicine with over 15 years of clinical research experience. She specializes in oncology, hematology, cell and gene therapy, CAR-T, radiopharmaceuticals, and multinational Phase I–IV trials. Rachel has proven expertise in trial operations, site management, regulatory compliance, budgeting, vendor oversight, and cross-functional team leadership across US and global studies., avatar=Image{width=1010,height=1305,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Rachel%20Piacente_pic.jpg',altText='Rachel Piacente_pic',fileId=217303397279}, lastname=Piacente, hs_initial_published_at=1784230182153, hs_created_by_user_id=65712240, hs_created_at=1784228917126, hs_is_edited=false, hs_deleted_at=0, name=Rachel, job=Clinical Trial Manager , slug=rachel-piacente, hs_updated_by_user_id=51739740}, second={hs_id=217314606343, hs_child_table_id=0, hs_updated_at=1784229356581, hs_published_at=1785259834087, description=Jennifer Coates is a Project Manager at Precision for Medicine with over a decade of clinical research experience supporting global clinical trials across multiple phases of development and a broad spectrum of therapeutic areas. She specializes in driving the successful execution of theranostic and other complex clinical programs, providing operational leadership to cross-functional teams while ensuring compliance with regulatory requirements and quality standards. Jennifer is known for fostering strong partnerships with sponsors and study teams, enabling collaboration, operational excellence, and the production of high-quality project deliverables., avatar=Image{width=2185,height=3261,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/JenCoates.jpeg',altText='JenCoates',fileId=217308893107}, lastname=Coates, hs_initial_published_at=1784230182153, hs_created_by_user_id=65712240, hs_created_at=1784228926906, hs_is_edited=false, hs_deleted_at=0, name=Jennifer, job=Project Manager, slug=jennifer-coates, hs_updated_by_user_id=51739740}, third={}})
  • Rachel P. avatar

    Rachel P.

  • Jennifer C. avatar

    Jennifer C.

Discover